FindTrial
Sign In

Urinary Marker for Oxidative Stress in Human Cisplatin- Induced Renal Injury

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00310739
Enrollment
Unknown
Registered
2006-04-04
Start date
Unknown
Completion date
Unknown
Last updated
2006-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Failure

Brief summary

We previously reported early measurement of urinary MDA might be a useful marker for the prediction of CDDP-induced renal damage in rat. The purpose of this clinical study is to test whether the changes of human urinary excretion of MDA, and can be used as early biomarker for the prediction of development of CDDP-induced ARF.

Interventions

None listed

Sponsors

Hamamatsu University
Lead SponsorOTHER

Study design

Observational model
NATURAL_HISTORY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Hospitalized patients have neck cancer

Countries

Japan

Contacts

Primary ContactTakayuki Tsuji, MD
tsu@hama-med.ac.jp+81-53-435-2261

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026